admin
In an era saturated with information, where news and media headlines often oscillate between sensationalized hope and stark dread, the way scientific findings are communicated to the public has become a matter of paramount concern. Fast-spreading articles frequently make bold claims of miraculous new treatments or alarming increases in harm linked to everyday exposures, yet a pervasive issue undermines the public’s understanding: the preferential use of relative risk over absolute risk in conveying scientific data. This nuanced but critical distinction can dramatically skew perception, leading to widespread misinterpretations, unwarranted panic, or a false sense of security, ultimately eroding public trust in science and evidence-based decision-making.
At the forefront of this discourse is Neal Asthana, a multi-disciplinary professional from the Washington D.C. area, whose lifelong passion for science and education culminated in the founding of Caveat Scientia. This passion project is dedicated to bridging the often-significant gap between complex scientific research and comprehensible public understanding. With a robust academic background, including a Bachelor of Marine Science from the University of Sydney and a Master of Science from the University of Miami Rosenstiel School of Marine and Atmospheric Science (RSMAS), Asthana brings a unique blend of scientific rigor and practical communication experience to this challenge. His diverse career, ranging from marine technician and educator at the Smithsonian Marine Station to aquarist at the Patricia & Phillip Frost Museum of Science, and currently as co-owner and President of the global cybersecurity company World Informatix, underscores his ability to translate intricate concepts across various domains. This unique vantage point, coupled with his creative outlet as an electronic dance music producer under the pseudonym Surge.DJ, positions him as a strong advocate for clear, impactful communication in all fields, particularly science.
Understanding the Core Discrepancy: Relative vs. Absolute Risk
The fundamental problem lies in the distinction between two primary measures of risk. In simple terms, relative risk answers the question: "How much bigger or smaller is the risk compared to another group?" For example, a headline might proclaim that a certain activity "doubles your risk" of a particular condition. This statement focuses on the ratio of risk between an exposed group and a control group. Conversely, absolute risk addresses a more personal and direct question: "How likely is this to happen in the first place, or to me?" It quantifies the actual probability of an event occurring within a given population or for an individual.
Consider a scenario where a rare disease affects 1 in 100,000 people. If a new factor is found to "double the risk," the relative risk increase is 100%. This sounds alarming. However, the absolute risk only increases from 0.001% to 0.002%, meaning the disease would now affect 2 in 100,000 people. While the relative increase is substantial, the absolute change for any individual remains infinitesimally small. This disparity is precisely where the potential for public misunderstanding takes root.
The Allure of Relative Risk: Media, Psychology, and Scientific Practice
The reasons behind the widespread adoption of relative risk are multifaceted, stemming from both media imperatives and scientific tradition. For news outlets, blogs, and social media platforms vying for attention in a crowded digital landscape, relative risk is a powerful tool. Headlines proclaiming that a treatment "cuts a risk in half" or an everyday exposure can "double your risk" are inherently more dramatic and urgent than those stating a marginal percentage point change in absolute terms. This taps directly into human psychology, which is often more responsive to magnitudes of change than to raw probabilities, especially when dealing with small baseline risks. The pursuit of clicks, shares, and audience engagement often prioritizes sensationalism over granular accuracy.
Within scientific publications, relative risk serves a logical and legitimate purpose. The scientific method relies heavily on testing hypotheses by comparing a control group against a condition where a variable has been manipulated. Relative risk provides a clear, concise way to summarize these comparative findings and the statistical significance of the observed effects. It allows researchers to quantify the strength of an association between an exposure and an outcome, making it easier to compare results across different studies and populations. For a scientist immersed in statistical analysis, presenting findings in relative terms often makes perfect sense within the confines of academic discourse. The issue, as Asthana and other science communicators highlight, arises when these meticulously derived findings are stripped of their contextual nuances and translated into mass-market headlines without the crucial addition of absolute risk.
Case Studies in Misinformation: The Pervasive Impact
One of the most widely cited examples of relative risk leading to public confusion involves the headline, "Alcohol consumption leads to a 61% increased risk of breast cancer in women," which spread globally following a meta-analysis published in the British Journal of Cancer (Bagnardi et al., 2015). This stunning figure ignited fear among women worldwide and prompted national-level discussions about the risks of alcohol. While the 61% figure was statistically accurate as a relative risk increase, the true impact of these findings was largely lost in translation.
To contextualize this, consider the baseline absolute risk of breast cancer for women in many developed countries. Approximately 1 in 8 women (around 12.5%) will develop breast cancer over their lifetime. If a specific level of alcohol consumption leads to a 61% relative increase, it does not mean that 61% of women who drink will get breast cancer. Instead, it means that if the baseline risk is 12.5%, the risk for women consuming alcohol at that level increases by 61% of that baseline. This translates to an absolute risk increase of approximately 7.6 percentage points (0.61 * 0.125 = 0.07625). So, instead of 12.5% of women developing breast cancer, around 20.1% (12.5% + 7.6%) might. While any increase in cancer risk is serious, the difference between a 61% relative increase and an absolute increase from 12.5% to 20.1% (or roughly 7 to 8 more cases per 100 women) is profound in terms of individual perception and societal panic. The headline’s dramatic framing often overshadowed the nuanced reality.
Beyond cancer, the implications of miscommunicated risk extend to various public health domains. During the COVID-19 pandemic, discussions around vaccine efficacy frequently highlighted relative risk reductions. A vaccine boasting "95% efficacy" meant a 95% reduction in the relative risk of developing symptomatic COVID-19 compared to an unvaccinated group in clinical trials. While incredibly effective, some segments of the public misinterpreted this as meaning only 5% of vaccinated individuals would contract the virus, or that the vaccine offered near-absolute immunity, leading to confusion when breakthrough infections occurred. The absolute risk reduction, which depends on the baseline incidence of the disease in the population, was often less emphasized, potentially contributing to vaccine hesitancy or a false sense of invincibility.
Similarly, discussions around medication side effects often fall victim to this same trap. A new drug might be found to "double the risk" of a rare adverse event. If the baseline risk of that event is 0.01% (1 in 10,000), doubling it to 0.02% (2 in 10,000) is still a very low absolute risk, which a patient might deem acceptable given the benefits of the drug. However, the "doubled risk" headline might trigger undue alarm and lead individuals to reject potentially life-saving treatments.
Risk Communication: A Challenge Beyond Media Headlines
The problem of miscommunicating risk extends far beyond sensationalized news articles, permeating deeply scientific domains such as clinical research and public policy. The intersection between scientists, clinicians, and policymakers necessitates a careful deliberation about how scientific results are presented from a communication standpoint.
Ample research has illuminated this phenomenon. A study by Brown (2022) concluded that "relative risk reduction: misinformative measure in clinical trials and COVID-19 vaccine efficacy." It argued that absolute risk reduction is a more precise and reliable measure of treatment and vaccine efficacy, especially in clinical research studies, offering a clearer picture of actual benefit or harm. Another systematic review by Zipkin et al. (2014) found that "presentations including absolute risk reductions were better than those including relative risk reductions for maximizing accuracy and seemed less likely than presentations with relative risk reductions to influence decisions to accept therapy." This suggests that providing absolute risk empowers individuals to make more informed and less emotionally driven decisions about their health.
An editorial in the Journal of Clinical Hypertension (Jiroutek & Turner, 2019) further underscores this issue within clinical settings. It provided an example where two different drugs might both show a "50% reduction" in a particular outcome (relative risk). However, if one drug was tested on a cohort with a very high baseline risk of the outcome and the other on a cohort with a very low baseline risk, the absolute number of lives saved or adverse events prevented could be vastly different—orders of magnitude higher for the drug affecting the high-risk population. Without presenting the absolute figures, clinicians and patients could easily misinterpret the true clinical significance of each treatment. These examples demonstrate the significant skewing power of using relative risk in isolation, impacting everything from individual patient choices to large-scale public health strategies.
Towards a New Paradigm: Strategies for Transparent Risk Communication
Recognizing the profound implications of this communication gap, there has been significant discourse amongst the science community regarding how to communicate risks responsibly. Neal Asthana and Caveat Scientia advocate for a new norm, emphasizing that the transparent presentation of absolute risk is a core component of honest scientific communication.
Several actionable strategies can facilitate this shift:
- Mandatory Inclusion of Absolute Risk: Every research paper, press release, and news article reporting risk findings should ideally present both relative and absolute risk measures. This dual presentation provides immediate context and allows for a more complete understanding.
- Visual Aids and Infographics: As highlighted by the original article’s implicit suggestion, using clear graphics can dramatically improve comprehension. Visual representations, such as "100-person arrays" (where a grid of 100 people shows how many are affected with and without a risk factor), bar charts, or simple Venn diagrams, can make absolute risks intuitively understandable, even for those without a statistical background.
- Contextualization and Caveats: Scientific findings should always be accompanied by clear explanations of the baseline risk, the specific population studied, the limitations of the research, and the applicability of the findings to different demographics. Simplifying complex statistical concepts into layman’s terms is crucial.
- Training and Education: There is a pressing need for improved scientific literacy among journalists and enhanced communication skills among scientists. Journalists should be trained to critically evaluate statistical claims and demand absolute risk figures, while scientists should be equipped with the tools to translate their complex research into accessible language for public consumption.
- Role of Public Health Organizations: Leading health bodies and government agencies have a responsibility to model best practices in risk communication. By consistently providing both relative and absolute risks in their public health messaging, they can set a standard for the industry.
- "Number Needed to Treat (NNT)" or "Number Needed to Harm (NNH)": These metrics, often used in clinical research, provide an absolute measure of how many people need to receive a treatment for one person to benefit (NNT) or how many need to be exposed to a factor for one person to experience harm (NNH). Incorporating these into public discourse can offer further clarity.
Looking Towards the Future: Rebuilding Trust in a Hyper-Connected World
In our modern era, characterized by hyperbole, hype, scientific miscommunication, and a troubling erosion of trust in science and evidence, the imperative for honest and clear communication of scientific research extends far beyond the confines of published journals. The rapid dissemination of information, often unfiltered and uncontextualized, necessitates a robust framework for presenting complex data responsibly.
By proactively creating a new norm of standards for scientific communication across the industry—from researchers and academic institutions to journalists, policymakers, and public health officials—society can begin to address the widespread misuse and misunderstanding of scientific findings. This collective effort is not merely about statistical accuracy; it is about fostering an informed citizenry capable of making sound decisions regarding their health, environment, and societal policies. Rebuilding trust in scientific institutions hinges on transparency, clarity, and an unwavering commitment to presenting the full picture, ensuring that the public is empowered with genuine understanding, not just sensational headlines. Neal Asthana’s mission with Caveat Scientia embodies this crucial vision, advocating for a future where science is not only discovered but also truly understood by all.
References:
(1) Bagnardi, V., Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V., Scotti, L., Jenab, M., Turati, F., Pasquali, E., Pelucchi, C., Galeone, C., Bellocco, R., Negri, E., Corrao, G., Boffetta, P., La Vecchia, C. (2015). Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis. British Journal of Cancer, 112(3), 580-593. https://doi.org/10.1038/bjc.2014.579
(2) Brown, R. B. (2022). Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy. Dialogues in Health, 1, 100074. https://doi.org/10.1016/j.dialog.2022.100074
(3) Zipkin, D. A., Umscheid, C. A., Keating, N. L., Allen, E., Aung, K., Schuur, J. D., & Korenstein, D. (2014). Evidence-based risk communication: A systematic review. Annals of Internal Medicine, 161(4), 270–280. https://doi.org/10.7326/M14-0295
(4) Jiroutek, M.R., & Turner, J.R. (2019). Relative vs absolute risk and odds: Understanding the difference. Journal of Clinical Hypertension (Greenwich), 21(6), 859-861. https://doi.org/10.1111/jch.13548
